https://doi.org/10.1074/jbc.m112.431312
S
Shugui Chen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
28
Papers
1.0K
Citations
15
h-index
18
i10-index
Shugui Chen is an academic researcher from GlaxoSmithKline (United States). The author has contributed to research in topics: Prion Diseases and Protein Misfolding & Chronic Myeloid Leukemia Treatments & Alzheimer's disease research and treatments. The author has an h-index of 15, co-authored 24 publications.
Papers by this author
worksEnhanced SH3/Linker Interaction Overcomes Abl Kinase Activation by Gatekeeper and Myristic Acid Binding Pocket Mutations and Increases Sensitivity to Small Molecule Inhibitors*
2013 · Journal of Biological Chemistry · 32 citations
Reply to Kascsak: Definition of the PrP 3F4 Epitope Revisited
2010 · Journal of Biological Chemistry · 0 citations
https://doi.org/10.1074/jbc.n109.088831
Schematic representation of PK-resistant fragments in rPrP<sup>Sc</sup> corresponding to Type 1 (MM1) and Type 2 (MM2) sCJD prions and molecular characteristics of purified human rPrPSc used in structural studies.
2015 · Figshare · 0 citations
https://doi.org/10.1371/journal.ppat.1004832.g001
Source, biophysical characteristics, and replication rate of Type 1 and Type 2 sCJD prions.
2015 · Figshare · 0 citations
https://doi.org/10.1371/journal.ppat.1004832.t001
Deuterium incorporation for peptic fragments derived from MM1 rPrP<sup>Sc</sup> (red) and MM2 rPrP<sup>Sc</sup>(blue).
2015 · Figshare · 0 citations
https://doi.org/10.1371/journal.ppat.1004832.g003
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat